Nurix
Frederick Cohen holds a Ph.D. in Organic Chemistry from UC Irvine and a B.A. in Chemistry from Occidental College. Starting as a Research Associate at Tularik, Frederick advanced through various roles in different companies such as Genentech, Achaogen, and now currently at Nurix Therapeutics where Frederick is the Vice President of Medicinal, Analytical, and Computational Chemistry. With extensive experience and expertise, their career has evolved from Scientist to Chemistry Team Leader.
This person is not in any offices
Nurix
3 followers
Nurix Therapeutics discovers drugs that harness the body's natural process to control protein levels. Nurix is focused on developing drugs to treat cancer including the novel, small molecule immuno-oncology agents.